Crowley Elizabeth's Form 4 filing
Celldex Therapeutics, Inc. (CLDX) · filed Nov 3, 2021
- Accession no.
- 0001179110-21-009816
- Filed
- Nov 3, 2021
- Trade date
- Nov 1, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $186.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crowley ElizabethCIK 0001681854 | Officer (Sr. VP &CPDO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2021 | Common Stock | MOption exerciseAcquired | +8,555 | $2.78 | +$23,782.9 | 9,043 | Direct | |
| Nov 1, 2021 | Common Stock | SSaleDisposed | −2,528 | $44.12 | −$111,535.36 | 6,515 | Direct | |
| Nov 1, 2021 | Common Stock | SSaleDisposed | −600 | $43.11 | −$25,866 | 5,915 | Direct | |
| Nov 1, 2021 | Common Stock | SSaleDisposed | −1,189 | $41.62 | −$49,486.18 | 4,726 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2021 | Common Stock | MOption exerciseDisposed | −8,555 | $0.00 | $0 | 34,445 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.